Zai Lab (ZLAB) Receives U.S. FDA Fast Track Designation for ZL-1310 May 19, 2025 07:02AM
Zai Lab Limited (ZLAB) Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 Jan 22, 2025 11:16PM
Zai Lab (ZLAB) Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia Jan 17, 2025 07:30AM
Zai Lab (ZLAB) and Vertex (VRTX) Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore Jan 10, 2025 07:32AM
Zai Lab (ZLAB) Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China Oct 29, 2024 07:31AM


Aug 27, 2024 08:32AM Zai Lab (ZLAB) to Present Preliminary Data From Phase 1 Trial of ZL-1218
Jul 15, 2024 02:53PM Zai Lab (ZLAB) -Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers